No Data
No Data
No Data
No Data
No Data
Express News | Trading Halt: Halt Status Updated at 9:00:00 AM ET: Quotation Resumption: News and Resumption Times
Moomoo 24/7Apr 4 09:00 ET
EFFECTOR Therapeutics Announces Topline Results of Phase 2 KICKSTART Trial of Tomivosertib Combined With Pembrolizumab in Non-Small Cell Lung Cancer
Yahoo FinanceApr 4 08:30 ET
Express News | Trading Halt: Halted at 8:25:00 A.m. ET - Trading Halt: Halt News Pending
Moomoo 24/7Apr 4 08:25 ET
Trading Halt: Halt Status Updated at 9:10:00 AM ET: Quotation Resumption: News and Resumption Times
Trading Halt: Halt Status Updated at 9:10:00 AM ET: Quotation Resumption: News and Resumption Times
BenzingaJan 12 09:10 ET
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
Trading Halt: Halted at 7:50:00 P.m. ET - Trading Halt: Halt News Pending
BenzingaJan 11 19:50 ET
EFFECTOR Therapeutics (NASDAQ:EFTRW) Shares Down 13.1%
eFFECTOR Therapeutics, Inc. (NASDAQ:EFTRW – Get Rating) traded down 13.1% on Wednesday . The company traded as low as $0.10 and last traded at $0.12. 898 shares traded hands during trading, a decline
Defense WorldApr 20, 2023 03:26 ET
No Data
No Data